Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Sanfilippo Jennifer A	2. Date of Event Requiring Statement (MM/DD/YYYY) 9/5/2019	3. Issuer Name and Ticker or Trading Symbol MELINTA THERAPEUTICS, INC. /NEW/ [MLNT]
(Last)        (First)        (Middle) C/O MELINTA THERAPEUTICS, INC., 44 WHIPPANY ROAD	4. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                          _____ 10% Owner ___X___ Officer (give title below)        _____ Other (specify below) interim Chief Executive Office /
(Street) MORRISTOWN, NJ 07960       (City)              (State)              (Zip)	5. If Amendment, Date Original Filed(MM/DD/YYYY)	6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Melinta Common Stock	600	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Melinta Stock Option (right to buy)	(1)	4/19/2028	Melinta Common Stock	5600.0	$37.25	D
Melinta Restricted Stock Units	(2)	(2)	Melinta Common Stock	120000.0	(2)	D

Explanation of Responses:
(1)	One quarter of the shares vested on April 20, 2019, and the rest vest in essentially equal monthly amounts during the 36 month period beginning April 21, 2019.
(2)	The restricted stock units will vest in equal semi-annual installments over the two year period following May 16, 2019, subject to continued service with the Issuer through the applicable vesting date.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Sanfilippo Jennifer A C/O MELINTA THERAPEUTICS, INC. 44 WHIPPANY ROAD MORRISTOWN, NJ 07960	X		interim Chief Executive Office

Signatures
Russell E Causey		9/13/2019
**Signature of Reporting Person		Date